TY  - GEN
AU  - Karp,Judith E
AU  - Blackford,Amanda
AU  - Smith,B Douglas
AU  - Alino,Katrina
AU  - Seung,Amy Hatfield
AU  - Bolaños-Meade,Javier
AU  - Greer,Jacqueline M
AU  - Carraway,Hetty E
AU  - Gore,Steven D
AU  - Jones,Richard J
AU  - Levis,Mark J
AU  - McDevitt,Michael A
AU  - Doyle,L Austin
AU  - Wright,John J
TI  - Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
SN  - 1873-5835
PY  - 2010///0614
KW  - Adult
KW  - Aged
KW  - Allopurinol
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bone Marrow Transplantation
KW  - Combined Modality Therapy
KW  - Cytarabine
KW  - Disease-Free Survival
KW  - Female
KW  - Flavonoids
KW  - Follow-Up Studies
KW  - Heart Diseases
KW  - chemically induced
KW  - Humans
KW  - Hyperkalemia
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Piperidines
KW  - Polyamines
KW  - Premedication
KW  - Remission Induction
KW  - Risk
KW  - Sepsis
KW  - etiology
KW  - Sevelamer
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Tumor Lysis Syndrome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.leukres.2009.11.007
ER  -